Cell-free DNA (cfDNA) is an emerging biomarker that researchers are utilizing to detect diseases in patients, allowing physicians to accurately diagnose and treat patients at the individual level. A few applications that utilize cfDNA to detect diseases in IVD (in-vitro diagnostics) are non-invasive prenatal testing, circulating tumor DNA markers, transplant rejection using donor derived cfDNA and microbial cfDNA in identifying infectious agents (3,4,5,6). The current challenge in our laboratory is to measure cfDNA concentration from minimal volume of plasma after the extraction methods. Different methods of extraction yield various concentrations of dsDNA. Our laboratory develops the use of a modified PicoGreen kits and Biotek’s microplate reader to measure cfDNA concentration. This assay is being qualified to allow the laboratory to assess the yields of dsDNA after extraction method. Qualification includes performance for linearity, accuracy, precision and stability of standards. The study of this modified PicoGreen assay establishes the linearity assay range from 1ng/mL to 1200ng/mL (equivalent to 0.017 – 20 ng/uL of dsDNA) with the imprecision less than 20%. The accuracy study was verified using commercial material with a known concentration and a comparison method with Agilent’s Tape-station. The standards of this assay have 14 days stability. The modified PicoGreen assay’s performance metrics are evaluated and determined to be acceptable for laboratory’s purposes, to use as quality indicator in assessing the yield of dsDNA from laboratory’s extraction method.
","abstract_html":"<p>Cell-free DNA (cfDNA) is an emerging biomarker that researchers are utilizing to detect diseases in patients, allowing physicians to accurately diagnose and treat patients at the individual level. A few applications that utilize cfDNA to detect diseases in IVD (in-vitro diagnostics) are non-invasive prenatal testing, circulating tumor DNA markers, transplant rejection using donor derived cfDNA and microbial cfDNA in identifying infectious agents (3,4,5,6). The current challenge in our laboratory is to measure cfDNA concentration from minimal volume of plasma after the extraction methods. Different methods of extraction yield various concentrations of dsDNA. Our laboratory develops the use of a modified PicoGreen kits and Biotek’s microplate reader to measure cfDNA concentration. This assay is being qualified to allow the laboratory to assess the yields of dsDNA after extraction method. Qualification includes performance for linearity, accuracy, precision and stability of standards. The study of this modified PicoGreen assay establishes the linearity assay range from 1ng/mL to 1200ng/mL (equivalent to 0.017 – 20 ng/uL of dsDNA) with the imprecision less than 20%. The accuracy study was verified using commercial material with a known concentration and a comparison method with Agilent’s Tape-station. The standards of this assay have 14 days stability. The modified PicoGreen assay’s performance metrics are evaluated and determined to be acceptable for laboratory’s purposes, to use as quality indicator in assessing the yield of dsDNA from laboratory’s extraction method.</p>","abstract_has_math":false,"creators":["Quach, Huy T"],"institution":null,"degree_name":"Master of Science","degree_level":"Master's Thesis (Campus only Access)","degree_discipline":"Clinical Laboratory Sciences","degree_department":null,"school":null,"contributors":["Marla Vaughn","Maria C. DeSousa, JD, MPA, CLS"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2018,"date_issued":"2018-05-01T07:00:00Z","date_published":"2018-05-01T07:00:00Z","updated_at":"2026-07-24T02:04:51Z","subjects":["Modified PicoGreen Kit","Cell-free DNA","Biotechnology","Laboratory and Basic Science Research"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[]},"links":{"outbound_url":"https://scholar.dominican.edu/masters-theses/325","outbound_label":"Repository record","outbound_source":"dc:identifier"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Marla Vaughn","Maria C. DeSousa, JD, MPA, CLS"]},{"key":"dc:creator","label":"Author","values":["Quach, Huy T"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.available","label":"Dc Date Available","values":["2020-05-10T07:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Clinical Laboratory Sciences"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Master's Thesis (Campus only Access)"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Master of Science"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Modified PicoGreen Kit","Cell-free DNA","Biotechnology","Laboratory and Basic Science Research"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://scholar.dominican.edu/masters-theses/325"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Cell-free DNA (cfDNA) is an emerging biomarker that researchers are utilizing to detect diseases in patients, allowing physicians to accurately diagnose and treat patients at the individual level. A few applications that utilize cfDNA to detect diseases in IVD (in-vitro diagnostics) are non-invasive prenatal testing, circulating tumor DNA markers, transplant rejection using donor derived cfDNA and microbial cfDNA in identifying infectious agents (3,4,5,6). The current challenge in our laboratory is to measure cfDNA concentration from minimal volume of plasma after the extraction methods. Different methods of extraction yield various concentrations of dsDNA. Our laboratory develops the use of a modified PicoGreen kits and Biotek’s microplate reader to measure cfDNA concentration. This assay is being qualified to allow the laboratory to assess the yields of dsDNA after extraction method. Qualification includes performance for linearity, accuracy, precision and stability of standards. The study of this modified PicoGreen assay establishes the linearity assay range from 1ng/mL to 1200ng/mL (equivalent to 0.017 – 20 ng/uL of dsDNA) with the imprecision less than 20%. The accuracy study was verified using commercial material with a known concentration and a comparison method with Agilent’s Tape-station. The standards of this assay have 14 days stability. The modified PicoGreen assay’s performance metrics are evaluated and determined to be acceptable for laboratory’s purposes, to use as quality indicator in assessing the yield of dsDNA from laboratory’s extraction method.
"]},{"key":"dc:title","label":"Title","values":["Qualify Microplate Reader’s Specification and Establish the Acceptance Criteria for Modified PicoGreen Kit in Measuring cell-free DNA Concentration in Clinical Laboratory"]}]}],"canonical_facts":{"dc:contributor":["Marla Vaughn","Maria C. DeSousa, JD, MPA, CLS"],"dc:creator":["Quach, Huy T"],"dc:date.available":["2020-05-10T07:00:00Z"],"dc:description.abstract":["Cell-free DNA (cfDNA) is an emerging biomarker that researchers are utilizing to detect diseases in patients, allowing physicians to accurately diagnose and treat patients at the individual level. A few applications that utilize cfDNA to detect diseases in IVD (in-vitro diagnostics) are non-invasive prenatal testing, circulating tumor DNA markers, transplant rejection using donor derived cfDNA and microbial cfDNA in identifying infectious agents (3,4,5,6). The current challenge in our laboratory is to measure cfDNA concentration from minimal volume of plasma after the extraction methods. Different methods of extraction yield various concentrations of dsDNA. Our laboratory develops the use of a modified PicoGreen kits and Biotek’s microplate reader to measure cfDNA concentration. This assay is being qualified to allow the laboratory to assess the yields of dsDNA after extraction method. Qualification includes performance for linearity, accuracy, precision and stability of standards. The study of this modified PicoGreen assay establishes the linearity assay range from 1ng/mL to 1200ng/mL (equivalent to 0.017 – 20 ng/uL of dsDNA) with the imprecision less than 20%. The accuracy study was verified using commercial material with a known concentration and a comparison method with Agilent’s Tape-station. The standards of this assay have 14 days stability. The modified PicoGreen assay’s performance metrics are evaluated and determined to be acceptable for laboratory’s purposes, to use as quality indicator in assessing the yield of dsDNA from laboratory’s extraction method.
"],"dc:identifier":["https://scholar.dominican.edu/masters-theses/325"],"dc:subject":["Modified PicoGreen Kit","Cell-free DNA","Biotechnology","Laboratory and Basic Science Research"],"dc:title":["Qualify Microplate Reader’s Specification and Establish the Acceptance Criteria for Modified PicoGreen Kit in Measuring cell-free DNA Concentration in Clinical Laboratory"],"thesis:degree_discipline":["Clinical Laboratory Sciences"],"thesis:degree_level":["Master's Thesis (Campus only Access)"],"thesis:degree_name":["Master of Science"]},"updated_at":"2026-07-24T02:04:51Z"}